AI speeds target discovery, molecule design and trial analysis — mostly accelerating R&D rather than cutting headcount.
Moderate — AI is largely an accelerant; bench and clinical work remain human.
AI-driven drug-discovery platform partnering with big pharma.
Its BioNeMo stack and GPUs power AI drug-discovery pipelines.
$100,590 median pay
$84,150 median pay
$93,330 median pay
$93,330 median pay
$93,330 median pay
$93,330 median pay
AI industry card
Pharma & Drug Discovery is watch for workforce AI exposure. AI speeds target discovery, molecule design and trial analysis — mostly accelerating R&D rather than cutting headcount.
AIFear.com